Skip to main content
HR 1083 109th Congress House Crime and Law Enforcement Chemicals Commerce Drug abuse Drug industry Drug law enforcement Drug traffic Drugs Health Methamphetamine

Methamphetamine Reduction Act of 2005

Introduced: March 3, 2005 See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 4, 2005
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Mar 22, 2005
Referred to the Subcommittee on Health.
Mar 3, 2005
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 3, 2005
Introduced in House
 Plain-English summary Congressional Research Service

Methamphetamine Reduction Act of 2005 - Requires ephedrine alkaloids, including ephedrine and pseudoephedrine, to be listed in schedule V (drugs or other substances having a low potential for abuse, that have a currently accepted medical use in treatment in the United States, abuse of which may lead to limited physical or psychological dependence) of the Controlled Substances Act. Excepts ephedrine alkaloid when contained in a drug that: (1) is marketed or distributed lawfully in the United States under the Federal Food, Drug, and Cosmetic Act; and (2) cannot be easily used in the illicit production of methamphetamine. Provides that an ephedrine alkaloid when so contained shall be considered a listed chemical.

What's happening now April 4, 2005

Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

 Committees of jurisdiction 4
 Cosponsors 3
All 3 Democratic 1 Republican 2